MetaADEDB 2.0 @ LMMD
cyclobenzaprine
(VXEAYBOGHINOKW-UHFFFAOYSA-N)
Structure
SMILES
CN(CCC=C1c2ccccc2C=Cc2c1cccc2)C.Cl
Molecular Formula:
C20H22ClN
Molecular Weight:
311.848
Log P:
5.3558
Hydrogen Bond Acceptor:
1
Hydrogen Bond Donor:
1
TPSA:
3.24
CAS Number(s):
6202-23-9
Synonym(s)
1.
cyclobenzaprine
2.
Flexeril
3.
Lisseril
4.
cyclobenzaprine hydrochloride
External Link(s)
MeSHC004704
PubChem Compound22576
57515965
ChEBI3997
CHEMBLCHEMBL1200636
KEGGdr:D00772
Therapeutic Target DatabaseD0NN8N
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 29US FAERS
2SomnolenceFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
3DizzinessFAERS: 16US FAERS
4FatigueFAERS: 13US FAERS
5NauseaFAERS: 13US FAERS
6HeadacheFAERS: 12US FAERS
7PainFAERS: 12US FAERS
8AstheniaFAERS: 9US FAERS
9AnxietyFAERS: 8US FAERS
10Feeling abnormalFAERS: 8US FAERS
11AmnesiaFAERS: 7US FAERS
12ConstipationFAERS: 7US FAERS
13AngerFAERS: 6US FAERS
14Drug abuseFAERS: 6US FAERS
15HypersensitivityFAERS: 6US FAERS
16LethargyFAERS: 6US FAERS
17PalpitationsFAERS: 6US FAERS
18Pharmaceutical product complaintFAERS: 6US FAERS
19PruritusFAERS: 6US FAERS
20TremorFAERS: 6US FAERS
21Chest PainFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
22Incorrect dose administeredFAERS: 5US FAERS
23Incorrect drug administration durationFAERS: 5US FAERS
24MalaiseFAERS: 5US FAERS
25VomitingFAERS: 5US FAERS
26Abdominal PainFAERS: 4US FAERS
27Atrial FibrillationFAERS: 4US FAERS
28Cerebrovascular accidentFAERS: 4US FAERS
29Chest discomfortFAERS: 4US FAERS
30Inappropriate schedule of drug administrationFAERS: 4US FAERS
31Mental status changesFAERS: 4US FAERS
32NystagmusFAERS: 4US FAERS
33OverdoseFAERS: 4US FAERS
34Restless Legs SyndromeFAERS: 4US FAERS
35Toxicity to various agentsFAERS: 4US FAERS
36AbasiaFAERS: 3US FAERS
37ArthralgiaFAERS: 3US FAERS
38Back PainFAERS: 3US FAERS
39DiscomfortFAERS: 3US FAERS
40Drug prescribing errorFAERS: 3US FAERS
41Drug toxicityFAERS: 3US FAERS
42Erythema MultiformeFAERS: 3US FAERS
43ErythemaFAERS: 3US FAERS
44FormicationFAERS: 3US FAERS
45HypersomniaFAERS: 3US FAERS
46Joint swellingFAERS: 3US FAERS
47Medication ErrorFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
48Memory impairmentFAERS: 3US FAERS
49MyalgiaFAERS: 3US FAERS
50MyoclonusFAERS: 3US FAERS
51RestlessnessFAERS: 3US FAERS
52SyncopeFAERS: 3US FAERS
53TachycardiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
54TorticollisFAERS: 3US FAERS
55UrticariaFAERS: 3US FAERS
56Abdominal discomfortFAERS: 2US FAERS
57Accidental exposureFAERS: 2US FAERS
58Activities of daily living impairedFAERS: 2US FAERS
59Adverse eventFAERS: 2US FAERS
60Cardiac ArrestFAERS: 2US FAERS
61Completed SuicideFAERS: 2US FAERS
62CryingFAERS: 2US FAERS
63DeliriumFAERS: 2US FAERS
64Drug dispensing errorFAERS: 2US FAERS
65Drug screen false positiveFAERS: 2US FAERS
66DysarthriaFAERS: 2US FAERS
67Impaired driving abilityFAERS: 2US FAERS
68IncoherentFAERS: 2US FAERS
69Macular degenerationFAERS: 2US FAERS
70Myocardial InfarctionFAERS: 2US FAERS
71NasopharyngitisFAERS: 2US FAERS
72NervousnessFAERS: 2US FAERS
73Neuroleptic Malignant SyndromeFAERS: 2US FAERS
74Peripheral swellingFAERS: 2US FAERS
75PhotophobiaFAERS: 2US FAERS
76Product use issueFAERS: 2US FAERS
77Protein total increasedFAERS: 2US FAERS
78Reaction to drug excipientsFAERS: 2US FAERS
79ScreamingFAERS: 2US FAERS
80Suicide attemptFAERS: 2US FAERS
81Therapeutic response unexpectedFAERS: 2US FAERS
82TinnitusFAERS: 2US FAERS
83Unevaluable eventFAERS: 2US FAERS
84Urinary RetentionFAERS: 2US FAERS
85VIIth nerve paralysisFAERS: 2US FAERS
86Wrong drug administeredFAERS: 2US FAERS
87nervous system disorderFAERS: 2US FAERS
88Accidental drug intake by childFAERS: 1US FAERS
89Age indeterminate myocardial infarctionFAERS: 1US FAERS
90AgeusiaFAERS: 1US FAERS
91AgitationFAERS: 1US FAERS
92Allergic reaction to excipientFAERS: 1US FAERS
93Angle Closure GlaucomaFAERS: 1US FAERS
94AnuriaFAERS: 1US FAERS
95AphasiaFAERS: 1US FAERS
96AsthenopiaFAERS: 1US FAERS
97AsthmaFAERS: 1US FAERS
98BedriddenFAERS: 1US FAERS
99BlepharospasmFAERS: 1US FAERS
100BlindnessFAERS: 1US FAERS
101Blood cholesterol increasedFAERS: 1US FAERS
102Burning sensationFAERS: 1US FAERS
103Cardiac FlutterFAERS: 1US FAERS
104CellulitisFAERS: 1US FAERS
105ChillsFAERS: 1US FAERS
106Cold sweatFAERS: 1US FAERS
107DehydrationFAERS: 1US FAERS
108Diabetes MellitusFAERS: 1US FAERS
109DisorientationFAERS: 1US FAERS
110Drug administration errorFAERS: 1US FAERS
111Drug dose omissionFAERS: 1US FAERS
112Drug effect delayedFAERS: 1US FAERS
113Drug ineffective for unapproved indicationFAERS: 1US FAERS
114Drug label confusionFAERS: 1US FAERS
115DysgeusiaFAERS: 1US FAERS
116DysphemiaFAERS: 1US FAERS
117DysphoniaFAERS: 1US FAERS
118DysuriaFAERS: 1US FAERS
119Emotional disorderFAERS: 1US FAERS
120Emotional distressFAERS: 1US FAERS
121Epinephrine increasedFAERS: 1US FAERS
122Erectile dysfunctionFAERS: 1US FAERS
123Expired product administeredFAERS: 1US FAERS
124Eye painFAERS: 1US FAERS
125False positive investigation resultFAERS: 1US FAERS
126Feeling ColdFAERS: 1US FAERS
127Feeling jitteryFAERS: 1US FAERS
128Flank PainFAERS: 1US FAERS
129FlatulenceFAERS: 1US FAERS
130FrustrationFAERS: 1US FAERS
131GlaucomaFAERS: 1US FAERS
132Gluten sensitivityFAERS: 1US FAERS
133HemiparesisFAERS: 1US FAERS
134HostilityFAERS: 1US FAERS
135InflammationFAERS: 1US FAERS
136Intentional drug misuseFAERS: 1US FAERS
137Intentional misuseFAERS: 1US FAERS
138Intentional product misuseFAERS: 1US FAERS
139Intentional self-injuryFAERS: 1US FAERS
140Intercepted drug administration errorFAERS: 1US FAERS
141Intestinal ObstructionFAERS: 1US FAERS
142Joint stiffnessFAERS: 1US FAERS
143Mental impairmentFAERS: 1US FAERS
144Mood swingsFAERS: 1US FAERS
145Musculoskeletal PainFAERS: 1US FAERS
146Musculoskeletal discomfortFAERS: 1US FAERS
147Musculoskeletal stiffnessFAERS: 1US FAERS
148MyocarditisFAERS: 1US FAERS
149Myoclonic EpilepsyFAERS: 1US FAERS
150Neck PainFAERS: 1US FAERS
151Non-cardiac chest painFAERS: 1US FAERS
152Oropharyngeal painFAERS: 1US FAERS
153Personality ChangeFAERS: 1US FAERS
154Physical abuseFAERS: 1US FAERS
155Poor quality drug administeredFAERS: 1US FAERS
156PresyncopeFAERS: 1US FAERS
157Product quality issueFAERS: 1US FAERS
158Product substitution issueFAERS: 1US FAERS
159Product use in unapproved indicationFAERS: 1US FAERS
160Reaction to excipientFAERS: 1US FAERS
161Rectal dischargeFAERS: 1US FAERS
162RetchingFAERS: 1US FAERS
163ScotomaFAERS: 1US FAERS
164SinusitisFAERS: 1US FAERS
165Skin lacerationFAERS: 1US FAERS
166SluggishnessFAERS: 1US FAERS
167SomnambulismFAERS: 1US FAERS
168Stevens-Johnson SyndromeFAERS: 1US FAERS
169StuporFAERS: 1US FAERS
170Sudden Cardiac DeathFAERS: 1US FAERS
171Therapeutic product contaminationFAERS: 1US FAERS
172Therapy cessationFAERS: 1US FAERS
173ThirstFAERS: 1US FAERS
174ThrombocytopeniaFAERS: 1US FAERS
175TrismusFAERS: 1US FAERS
176Unresponsive to stimuliFAERS: 1US FAERS
177Upper respiratory tract congestionFAERS: 1US FAERS
178Urinary tract infectionFAERS: 1US FAERS
179Urine flow decreasedFAERS: 1US FAERS
180VertigoFAERS: 1US FAERS
181Victim of child abuseFAERS: 1US FAERS
182Visual ImpairmentFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.